{
    "additionDate": "2021-12-04T05:50:54.421669Z",
    "biotoolsCURIE": "biotools:crispr_validation",
    "biotoolsID": "crispr_validation",
    "description": "Biomedical-Bioinformatics, a division of CD Genomics, uses CRISPR/Cas9 high-throughput screening technology to screen tumor cells positively or negatively, and can perform enrichment analysis on target candidate gene guide RNAs, which can mine tumor resistance genes or find new targets for tumor treatment point.",
    "editPermission": {
        "type": "private"
    },
    "homepage": "https://bmb.cd-genomics.com/crispr-validation.html",
    "lastUpdate": "2021-12-04T05:50:54.424401Z",
    "name": "CRISPR Validation",
    "owner": "cd-genomics.com"
}